Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice

The current standards for empirical broad-spectrum intravenous antibiotic (AB) treatment, combined with hospitalization, are cautious and safe, but lead to over-treatment of a substantial group of patients. We need to validate parameters to identify these low-risk febrile-neutropenia (FN) patients,...

Ausführliche Beschreibung